IL17A and non-small cell lung carcinoma: In agreement with this, high concentrations of IL-17A (50 to 500 ng/mL) significantly increased cell proliferation in a dose-dependent manner by high-mobility group A1 (HMGA1) upregulation in A549 NSCLC cells [2,8].